Mount Sinai Logo

Hugh Biller

  • PROFESSOR EMERITUS Otolaryngology
Print ProfilePrint Profile


Plasse T, Ohnuma T, Brooks S, Saponara E, Holland J, Biller H. Bleomycin infusion followed by cyclophosphamide, methotrexate and fluorouracil in advanced squamous carcinoma of the head and neck. Cancer 1984; 53: 841-843.

Urken ML, Moscoso J, Lawson W, Biller H. A systematic approach to functional reconstruction of the oral cavity following partial and total glossectomy. Archives of Otolaryngology/Head and Neck Surgery 1994; 120: 589-601.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr.Biller is not currently required to report Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central